Correlation Between X4 Pharmaceuticals and Corbus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Corbus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Corbus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Corbus Pharmaceuticals Holding, you can compare the effects of market volatilities on X4 Pharmaceuticals and Corbus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Corbus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Corbus Pharmaceuticals.
Diversification Opportunities for X4 Pharmaceuticals and Corbus Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between XFOR and Corbus is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Corbus Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corbus Pharmaceuticals and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Corbus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corbus Pharmaceuticals has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Corbus Pharmaceuticals go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Corbus Pharmaceuticals
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 3072.33 times less return on investment than Corbus Pharmaceuticals. But when comparing it to its historical volatility, X4 Pharmaceuticals is 2.05 times less risky than Corbus Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Corbus Pharmaceuticals Holding is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 370.00 in Corbus Pharmaceuticals Holding on August 27, 2024 and sell it today you would earn a total of 1,377 from holding Corbus Pharmaceuticals Holding or generate 372.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Corbus Pharmaceuticals Holding
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Corbus Pharmaceuticals |
X4 Pharmaceuticals and Corbus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Corbus Pharmaceuticals
The main advantage of trading using opposite X4 Pharmaceuticals and Corbus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Corbus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corbus Pharmaceuticals will offset losses from the drop in Corbus Pharmaceuticals' long position.| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
| Corbus Pharmaceuticals vs. Trevi Therapeutics | Corbus Pharmaceuticals vs. Cue Biopharma | Corbus Pharmaceuticals vs. AN2 Therapeutics | Corbus Pharmaceuticals vs. Bioatla |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |